BACKGROUND AND OBJECTIVES: South Asians (SAs) comprise 25% of all Canadian visible minorities. SAs constitute a group at high risk for cardiovascular disease in the general population, but the risk in SA kidney transplant recipients has never been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a cohort study of 864 kidney recipients transplanted from 1998 to 2007 and followed to June 2009, we identified risk factors including ethnicity associated with major cardiac events (MACEs, a composite of nonfatal myocardial infarction, coronary intervention, and cardiac death) within and beyond 3 months after transplant. Kaplan-Meier methodology and multivariate Cox regression analysis were used to determine risk factors for MACEs. RESULTS: There was no difference among SAs (n = 139), whites (n = 550), blacks (n = 65), or East Asians (n = 110) in baseline risk, including pre-existing cardiac disease. Post-transplant MACE rate in SAs was 4.4/100 patient-years compared with 1.31, 1.16, and 1.61/100 patient-years in whites, blacks, and East Asians, respectively (P < 0.0001 versus each). SA ethnicity independently predicted MACEs along with age, male gender, diabetes, systolic BP, and prior cardiac disease. SAs also experienced more MACEs within 3 months after transplant compared with whites (P < 0.0001), blacks (P = 0.04), and East Asians (P = 0.006). However, graft and patient survival was similar to other groups. CONCLUSIONS: SA ethnicity is an independent risk factor for post-transplant cardiac events. Further study of this high-risk group is warranted.
BACKGROUND AND OBJECTIVES: South Asians (SAs) comprise 25% of all Canadian visible minorities. SAs constitute a group at high risk for cardiovascular disease in the general population, but the risk in SA kidney transplant recipients has never been studied. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a cohort study of 864 kidney recipients transplanted from 1998 to 2007 and followed to June 2009, we identified risk factors including ethnicity associated with major cardiac events (MACEs, a composite of nonfatal myocardial infarction, coronary intervention, and cardiac death) within and beyond 3 months after transplant. Kaplan-Meier methodology and multivariate Cox regression analysis were used to determine risk factors for MACEs. RESULTS: There was no difference among SAs (n = 139), whites (n = 550), blacks (n = 65), or East Asians (n = 110) in baseline risk, including pre-existing cardiac disease. Post-transplant MACE rate in SAs was 4.4/100 patient-years compared with 1.31, 1.16, and 1.61/100 patient-years in whites, blacks, and East Asians, respectively (P < 0.0001 versus each). SA ethnicity independently predicted MACEs along with age, male gender, diabetes, systolic BP, and prior cardiac disease. SAs also experienced more MACEs within 3 months after transplant compared with whites (P < 0.0001), blacks (P = 0.04), and East Asians (P = 0.006). However, graft and patient survival was similar to other groups. CONCLUSIONS: SA ethnicity is an independent risk factor for post-transplant cardiac events. Further study of this high-risk group is warranted.
Authors: C M Fischbacher; R Bhopal; M K Rutter; N C Unwin; S M Marshall; M White; K G M M Alberti Journal: Diabet Med Date: 2003-01 Impact factor: 4.359
Authors: R C Hoogeveen; J K Gambhir; D S Gambhir; K T Kimball; K Ghazzaly; J W Gaubatz; M Vaduganathan; R S Rao; M Koschinsky; J D Morrisett Journal: J Lipid Res Date: 2001-04 Impact factor: 5.922
Authors: S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen Journal: Lancet Date: 2000-07-22 Impact factor: 79.321
Authors: Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen Journal: Lancet Date: 2003-06-14 Impact factor: 79.321
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Annaswamy Raji; Marie D Gerhard-Herman; Mercedes Warren; Stuart G Silverman; Vassilios Raptopoulos; Christos S Mantzoros; Donald C Simonson Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958
Authors: Tazeen H Jafar; Muhammad Islam; Saleem Jessani; Rasool Bux; Lesley A Inker; Christophe Mariat; Andrew S Levey Journal: Am J Kidney Dis Date: 2011-08-15 Impact factor: 8.860
Authors: Machiel A Siezenga; Prataap K Chandie Shaw; Mohamed R Daha; Ton J Rabelink; Stefan P Berger Journal: Cardiovasc Diabetol Date: 2011-07-05 Impact factor: 9.951
Authors: Kyung Don Yoo; Clara Tammy Kim; Myoung-Hee Kim; Junhyug Noh; Gunhee Kim; Ho Kim; Jung Nam An; Jae Yoon Park; Hyunjeong Cho; Kyoung Hoon Kim; Hyunwook Kim; Dong-Ryeol Ryu; Dong Ki Kim; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889
Authors: G V Ramesh Prasad; Leon Vorobeichik; Michelle M Nash; Michael Huang; Lindita Rapi; Graham Maguire; Muhammad Mamdani; Andrew T Yan; Philip W Connelly Journal: Clin Kidney J Date: 2012-04